Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors

BACKGROUND: Nasopharyngeal carcinoma (NPC), a highly invasive tumor, exhibits a distinctive racial and geographic distribution. As options of agents for effective combination chemoradiotherapy for advanced NPC are limited, novel therapeutic approaches are desperately needed. Here the potential of si...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihai, Zuo, Wenqi, Zeng, Quan, Qian, Yi, Li, Yanshi, Liu, Chuan, Wang, Jue, Zhong, Shixun, Bu, Youquan, Hu, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360700/
https://www.ncbi.nlm.nih.gov/pubmed/30717758
http://dx.doi.org/10.1186/s12929-019-0507-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360700/
https://www.ncbi.nlm.nih.gov/pubmed/30717758
http://dx.doi.org/10.1186/s12929-019-0507-z

Ejemplares similares